Capula Management LTD Moderna, Inc. Call Options Transaction History

Capula Management LTD

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 03, 2023	SELL	$96.41 - $126.61 $1.28 Million - $1.68 Million	-13,300 Reduced 70.0%	5,700 $588,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $4.27 Million - $5.78 Million	-36,000 Reduced 65.45%	19,000 $2.31 Million
Q1 2023 May 10, 2023	BUY	$135.66 - $197.02 $7.46 Million - $10.8 Million	55,000 New	55,000 $8.45 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.